Friday, April 19, 2024 4/19/2024

Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes

Award Number: R01EB027113
ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

There are a number of diseases and conditions in the middle ear that cause hearing loss in both children and adults. In children it is particularly important to expedite interventions to restore hearing since it negatively impacts language development and academic performance. An example is cholesteatoma, a benign lesion due to abnormal skin growth in the middle ear which facilitates erosion of bone, including the ossicles, causing permanent damage. The preferred surgical approach comes with a relatively high risk of both recurrent and residual lesions (~10%). While the initial diagnosis is typically straight forward because of the size of the lesion when the patient seeks medical care, identifying residual cholesteatoma after the initial resection has been performed is difficult even using advanced MRI and CT techniques. Consequently, “second look” surgeries are frequently preformed to verify that the middle ear is lesion free. An imaging solution able to identify cholesteatoma lesions in the clinic could substantially reduce the number of second look surgeries and their associated costs and potential co-morbidities (e.g. sensorineural hearing loss, vertigo and surgical trauma to the facial nerve). Disruption of the ossicular chain due to cholesteatoma or other etiologies (e.g. trauma, chronic otitis media, osteosclerosis) is commonly treated with ossicular replacement surgery to restore hearing. Unfortunately, the outcomes vary greatly. While the variation is not entirely understood, an accepted contributing factor is the choice of the length of the prostheses with loose fitting prostheses performing significantly better than tight fitting prostheses. However, there is currently no imaging technology that can provide pre- or intra-surgical quantitative guidance on optimal prosthetic length. Scar tissue formation around the prosthesis can also adversely affect hearing outcomes, and there is no reliable way to identify this problem. Therefore, if the outcome is poor it is often difficult to determine the cause and whether a revision surgery is indicated. Advanced optical imaging tools based on Optical Coherence Tomography (OCT) can largely fill this gap in imaging technology thus providing improved diagnostics, leading to better outcomes and lower health care costs. OCT has both the spatial and temporal resolution to measure the morphological features and the function of the ear. The challenge with utilizing OCT for interrogating the middle ear space is access. OCT can penetrate roughly 2 mm into tissue, hence access to the middle ear for imaging must be made via the ear canal or Eustachian tube. The technology development proposed here is directed at overcoming the access issue and enabling comprehensive functional and morphological imaging of the middle ear space. A set of pilot studies will address validation of our approach for specific pathologies where we believe an imaging solution can swiftly impact clinical care.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = $651,326 )
2022	2022	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	4	12/8/2021	NON-COMPETING CONTINUATION	$586,193
2022	2022	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	4	5/31/2022	NON-COMPETING CONTINUATION	$65,133
														Subtotal = $651,326

Issue Date FY: 2021 ( Subtotal = $644,204 )
2021	2021	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	001	3	5/27/2021	NON-COMPETING CONTINUATION	$0
2021	2021	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	3	3/17/2021	NON-COMPETING CONTINUATION	$644,204
														Subtotal = $644,204

Issue Date FY: 2020 ( Subtotal = $672,471 )
2020	2020	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	2	1/13/2020	NON-COMPETING CONTINUATION	$672,471
														Subtotal = $672,471

Issue Date FY: 2019 ( Subtotal = $670,541 )
2019	2019	UNIVERSITY OF SOUTHERN CALIFORNIA	3720 S FLOWER ST FL 3	LOS ANGELES	CA	90007	LOS ANGELES	USA	Discovery and Applied Research for Technological Innovations to Improve Human Health	000	1	3/22/2019	NEW	$670,541
														Subtotal = $670,541

Grand Total All Awards = $2,638,542

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Optical imaging technologies to identify residual cholesteatoma and improve ossiculoplasty outcomes

Award Number: R01EB027113

ORGANIZATION: NATIONAL INSTITUTE Of BIOMEDICAL IMAGING & BIOENGINEERING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer